Italia markets closed

Accuray Incorporated (ARAY)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
2,4700+0,0400 (+1,65%)
Alla chiusura: 04:00PM EDT
2,5400 +0,07 (+2,83%)
Dopo ore: 05:46PM EDT

Accuray Incorporated

1240 Deming Way
Madison, WI 53717-1954
United States
608 824 2800
https://www.accuray.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno1.024

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Ms. Suzanne Winter M.B.A.President, CEO & Director1,02MN/D1963
Mr. Ali PervaizSenior VP & CFO601,12kN/D1980
Mr. Michael HogeSenior Vice President of Global Operations540,12kN/D1967
Mr. Jesse ChewSenior VP, Chief Legal Officer & Company Secretary621,2kN/D1981
Mr. Sandeep ChalkeSenior VP & Chief Commercial Officer826,18kN/D1966
Ms. Gina CorradettiVP, Chief Accounting Officer, Principal Accounting Officer & ControllerN/DN/D1974
Mr. John M. DunnVice President, Chief Information & Security OfficerN/DN/DN/D
Beth KaplanPublic Relations DirectorN/DN/DN/D
Ms. Melanie GebauerVice President of Global Human ResourcesN/DN/DN/D
Mr. Juki HozumiPresident & GM of Japan RegionN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Governance aziendale

L'ISS Governance QualityScore di Accuray Incorporated al 1 marzo 2024 è 3. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 1; diritti degli azionisti: 5; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.